Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures.
BMP
Cell culture
Estrogen
Progenitors
TGFβ
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
15
02
2019
accepted:
09
04
2019
pubmed:
18
4
2019
medline:
26
11
2019
entrez:
18
4
2019
Statut:
ppublish
Résumé
Understanding how differentiation, microenvironment, and hormonal milieu influence human breast cell susceptibility to malignant transformation will require the use of physiologically relevant in vitro systems. We sought to develop a 3D culture model that enables the propagation of normal estrogen receptor alpha (ER) + cells. We tested soluble factors and protocols for the ability to maintain progenitor and ER + cells in cultures established from primary cells. Optimized conditions were then used to profile estrogen-induced gene expression changes in cultures from three pathology-free individuals. Long-term representation of ER + cells was optimal in medium that included three different TGFβ/activin receptor-like kinase inhibitors. We found that omitting the BMP signaling antagonist, Noggin, enhanced the responsiveness of the PGR gene to estradiol exposure without altering the proportions of ER + cells in the cultures. Profiling of estradiol-exposed cultures showed that while all the cultures showed immediate and robust induction of PGR, LRP2, and IGFB4, other responses varied qualitatively and quantitatively across specimens. We successfully identified conditions for the maintenance and propagation of functional ER + cells from normal human breast tissues. We propose that these 3D cultures will overcome limitations of conventional 2D cultures of partially or fully transformed cell lines by sustaining normal endocrine function and growth regulation of the cell populations that comprise intact breasts.
Identifiants
pubmed: 30993572
doi: 10.1007/s10549-019-05229-5
pii: 10.1007/s10549-019-05229-5
doi:
Substances chimiques
Biomarkers, Tumor
0
Receptors, Estrogen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-140Subventions
Organisme : California Breast Cancer Research Program
ID : 21UB-8012
Organisme : California Breast Cancer Research Program
ID : 17UB-8708
Organisme : Avon Foundation for Women
ID : L1779